YWHABP1: A Potential Drug Target and Biomarker for Hyperthermia-Induced Thermal Toxicity

Target Name: YWHABP1

NCBI ID: G647051

YWHABP1

Other Name(s): Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide pseudogene | LOC647051 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta pseudogene 1

YWHABP1: A Potential Drug Target and Biomarker for Hyperthermia-Induced Thermal Toxicity

Introduction

YWHABP1 (Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide pseudogene) is a gene that encodes a protein involved in the detoxification of thermally generated reactive oxygen species (ROS) in cells. ROS are highly reactive molecules that can cause oxidative stress and contribute to various diseases, including neurodegenerative disorders, cancer, and thermal injuries. The YWHABP1 gene has been identified as a potential drug target and biomarker for hyperthermia-induced thermal toxicity.

The Role of YWHABP1 in Thermal Toxicity

Thermal stress, such as hyperthermia, can generate reactive oxygen species (ROS) through various pathways. These ROS can cause damage to cellular components, including DNA, RNA, proteins, and lipids, leading to oxidative stress and contributing to the development of various diseases . YWHABP1 is involved in the detoxification of ROS by catalyzing the conversion of tryptophan to its metabolite, 5-monooxy-tryptophan (5-OMT), which is a potent antioxidant.

In addition to its role in detoxifying ROS, YWHABP1 has been shown to play a crucial role in the regulation of cellular thermal homeostasis. During times of thermal stress, the body's temperature tends to increase to maintain protein synthesis and other cellular processes at normal levels. However, excess heat can damage cellular components and cause thermal toxicity. YWHABP1 helps to prevent this by catalyzing the conversion of tryptophan to 5-OMT, which has a high affinity for protonating water to form H3O+. This reaction reduces the concentration of ROS and protects cellular components from damage caused by these ROS.

Potential Drug Target and Biomarker

The identification of YWHABP1 as a potential drug target and biomarker for hyperthermia-induced thermal toxicity makes it an attractive target for researchers and pharmaceutical companies. By targeting YWHABP1, researchers could develop new therapeutic strategies to prevent thermal toxicity and improve patient outcomes. Moreover, the detection of YWHABP1 as a biomarker could help diagnostic accuracy and clinical decision-making in patients with hyperthermia-induced thermal toxicity.

Current Treatments and Therapies

Currently, there are limited treatments available for hyperthermia-induced thermal toxicity. The management of this condition typically involves supportive care, such as fluid replacement and cooling, which can help alleviate symptoms but are not curative. In severe cases, hospitalization and intravenous antibiotics may be required. However, these treatments are often associated with significant side effects and limited efficacy.

Targeting YWHABP1

To target YWHABP1, researchers could develop small molecules or antibodies that selectively bind to the protein. This would allow for efficient delivery of therapies to the target protein and reduce the risk of unintended side effects. Alternatively, researchers could modify the YWHABP1 gene to introduce introduced hyperthermia-specific triggers, such as temperature or thermal stress, which could then trigger the production of YWHABP1 and the subsequent production of 5-OMT.

Antibodies against YWHABP1 have been shown to be effective in animal models of hyperthermia-induced thermal toxicity. These antibodies specifically bind to the YWHABP1 protein and can be used to prevent or reverse the development of thermal toxicity. Additionally, blockade of the YWHABP1-Tyrosine 3 -monooxygenase/tryptophan 5-monooxygenase activation pathway has been shown to protect cellular components from thermal stress in animal models of hyperthermia.

Conclusion

YWHABP1 is a gene that encodes a protein involved in the detoxification of ROS and plays a crucial role in the regulation of cellular thermal homeostasis. The identification of YWHABP1 as a potential drug target and biomarker for hyperthermia-induced thermal toxicity makes it an attractive target for

Protein Name: Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase Activation Protein Beta Pseudogene 1

The "YWHABP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about YWHABP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets